HXN6005: Clinical Trials

1 trial of HXN6005, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Not yet recruiting 1
Phase 21Not yet recruiting 1

Follow HXN6005: new trials by email Literature Review of HXN6005 trials Research Report on HXN6005

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of HXN6005 in Healthy Participants and Patients With Moderate-to-Severe Atopic Dermatitis
HXN6005, Placebo - Health Adult Subjects, Atopic Dermatitis (AD)
Phase 1 / Phase 2Not yet recruitingHelixon Biotechnology (Suzhou) Co., Ltd672026-09-012026-08-24

Conditions studied

Dermatitis, Atopic (1)

Sponsors

Helixon Biotechnology (Suzhou) Co., Ltd (1)

Countries

China (1)